Clinical trial
Thai Prophylactic HIV Vaccine Phase I Study
NCT00333424 · Kirby Institute, Other · Terminated
Key facts
| NCT number | NCT00333424 |
|---|---|
| Title | Thai Prophylactic HIV Vaccine Phase I Study |
| Official title | A Randomised, Placebo-Controlled, Double-Blind, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic pHIS-HIV-AE DNA Prime and rFPV-HIV-AE Boost HIV Vaccination Strategy |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | Thai Red Cross AIDS Research Centre |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Biological |
| Interventions | pHIS-HIV-AE (DNA vaccine) prime and rFPV-HIV-AE (recombinant fowlpox virus boost) vaccine |
| Enrollment | 8 |
| Start date | Aug 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Jun 5, 2006 |
| Last update posted | Jun 13, 2012 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: